Active — Not RecruitingPhase 2

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

United States175 participantsStarted 2023-10-25

Plain-language summary

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients with Nonalcoholic Steatohepatitis (MONARCH)

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis of type 2 diabetes OR
✓. Presence of 2 or more components of metabolic syndrome:

What they're measuring

Percent relative change from Baseline in liver-fat content assessed by MRI-PDFF (Cohort A and Cohort B)

Timeframe: Week 24

Trial details

NCT IDNCT06108219

SponsorCorcept Therapeutics

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-09

View on ClinicalTrials.gov More Nonalcoholic Steatohepatitis (NASH) trials